TSCAN THERAPEUTICS, INC. (TCRX) Net income 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$129.8MFY2025 · since FY2020: -$26.1M → -$129.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.8M | -1.8% |
| FY2024 | -$127.5M | -42.9% |
| FY2023 | -$89.2M | -34.7% |
| FY2022 | -$66.2M | -36.2% |
| FY2021 | -$48.6M | -86.1% |
| FY2020 | -$26.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice